0 followers
With a new and rapid technology to measure biomarkers, carefully benchmarked against current gold standards, we seek to drive a disruptive shift in capability, access, and precision of biomarker data for screening and diagnostics.
We aim to make Fragment synonymous with rapid biosensing.
Chamindie Punyadeera